1.      Bass JW, Freitas BC, Freitas AD, et al. Prospective randomized double-blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J. 1998;17(6):447-452. doi:10.1097/00006454-199806000-00002

2.      Bozlak S, Varkal MA, Yildiz I, et al. Cervical lymphadenopathies in children: a prospective clinical cohort study. Int J Pediatr Otorhinolaryngol. 2016;82:81-87. doi:10.1016/j.ijporl.2016.01.002

3.      Celebi G, Baruonu F, Ayoglu F, et al. Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses. Jpn J Infect Dis. 2006;59(4):229-234.

4.      Chiappini E, Camaioni A, Benazzo M, et al. Development of an algorithm for the management of cervical lymphadenopathy in children: consensus of the Italian Society of Preventive and Social Pediatrics. BMJ Paediatr Open. 2023;7(1):e001735. doi:10.1136/bmjpo-2022-001735

5.      Citak EC, Karadeniz C, Oguz A, et al. Cervical lymphadenopathy in childhood: is it really a problem? Pediatr Hematol Oncol. 2011;28(6):537-540. doi:10.3109/08880018.2011.566904

6.      D’Ippolito G, et al. Lymph node evaluation in pediatrics: what the radiologist needs to know. Pediatr Radiol. 2021;51:123-135.

7.      Grant CN, Aldrink J, Lautz TB, et al. Lymphadenopathy in children: a streamlined approach for the surgeon – a report from the APSA Cancer Committee. J Pediatr Surg. 2021;56(2):274-281. doi:10.1016/j.jpedsurg.2020.09.058

8.      King D, Ramachandra J, Yeomanson D. Lymphadenopathy in children: refer or reassure? Arch Dis Child Educ Pract Ed. 2014;99(3):101-110. doi:10.1136/archdischild-2013-304443

9.      Kliegman RM, St. Geme JW, Blum NJ, et al., eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2024.

10.  Leung AKC, Davies HD. Cervical lymphadenitis: etiology, diagnosis, and management. Curr Infect Dis Rep. 2009;11(3):183-189. doi:10.1007/s11908-009-0028-0

11.  McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927-e999. doi:10.1161/CIR.0000000000000484

12.  Oguz A, Karadeniz C, Temel EA, Citak EC, Okur FV. Evaluation of peripheral lymphadenopathy in children. Pediatr Hematol Oncol. 2006;23(7):549-561. doi:10.1080/08880010600856907

13.  Orkin SH, Nathan DG, Ginsburg D, et al. Nathan and Oski’s Hematology and Oncology of Infancy and Childhood. 8th ed. Philadelphia, PA: Elsevier Saunders; 2015.

14.  Rolain JM, Lepidi H, Zanaret M, et al. Lymph node biopsy specimens and diagnosis of cat-scratch disease. Emerg Infect Dis. 2006;12(9):1338-1344. doi:10.3201/eid1209.060122

15.  Soldes OS, Younger JG, Hirschl RB. Predictors of malignancy in childhood peripheral lymphadenopathy. J Pediatr Surg. 1999;34(10):1447-1452. doi:10.1016/S0022-3468(99)90101-X

16.  Tebruegge M, Bogyi M, Soriano-Arandes A, et al. Mycobacterial lymphadenitis in children: a prospective international study. Am J Respir Crit Care Med. 2023;208(1):61-71. doi:10.1164/rccm.202212-2252OC

17.  Twist CJ, Link MP. Assessment of lymphadenopathy in children. Pediatr Clin North Am. 2002;49(5):1009-1025. doi:10.1016/S0031-3955(02)00038-X

18.  Weinstock MS, Patel NA, Smith LP. Pediatric cervical lymphadenopathy. Pediatr Rev. 2018;39(9):433-443. doi:10.1542/pir.2017-0249

19.  Zimmermann P, Tebruegge M, Curtis N, et al. Management of nontuberculous mycobacterial cervicofacial lymphadenitis in children: a systematic review and meta-analysis. J Infect. 2015;71(1):9-18. doi:10.1016/j.jinf.2015.02.010